Evaluation and Natural History of Children With Cancer and AIDS

Led by National Cancer Institute (NCI) · Updated on 2008-03-04

110

Participants Needed

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Patients enrolled in this study will not receive investigational therapy. Any treatments rendered will be standard and based on appropriate medical care. Should a patient become eligible for an experimental therapy protocol, the normal process of enrollment and informed consent will be followed.

CONDITIONS

Brief Title

Evaluation and Natural History of Children With Cancer and AIDS

Who Can Participate

All Genders

Eligibility Criteria

Children with cancer (or a precancer syndrome) or HIV infection, between the age(s) of 3 months to 30 years, who are evaluated by the Pediatric Branch and are found to be not immediately eligible for an ongoing protocol but are likely to become a candidate for a future protocol.

Children with cancer (or a precancer syndrome) or HIV infection, who present with disease manifestations of special interest to Pediatric Branch investigators, because they are likely to shed light on disease.

Patients who, when evaluated by the Branch, are determined to likely never become eligible for a Pediatric Branch protocol are not eligible for this protocol.

No patients younger than 3 months of age or older than 30 years of age are eligible for this protocol.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Evaluation and Natural History of Children With Cancer and AIDS

On this page

AI-Summary

What this Trial Is About

Brief Title

Who Can Participate

Eligibility Criteria

Not the Right Trial for You?

On this page

Who Can Participate

Eligibility Criteria